nodes	percent_of_prediction	percent_of_DWPC	metapath
Haloperidol—ABCB1—colon cancer	0.29	1	CbGaD
Haloperidol—UGT1A9—Irinotecan—colon cancer	0.125	0.257	CbGbCtD
Haloperidol—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0416	0.0853	CbGbCtD
Haloperidol—CYP3A7—Irinotecan—colon cancer	0.0416	0.0853	CbGbCtD
Haloperidol—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.0364	0.0746	CbGbCtD
Haloperidol—CYP3A7—Vincristine—colon cancer	0.0364	0.0746	CbGbCtD
Haloperidol—CYP2C9—Capecitabine—colon cancer	0.0339	0.0695	CbGbCtD
Haloperidol—CYP3A5—Irinotecan—colon cancer	0.0312	0.064	CbGbCtD
Haloperidol—CYP3A5—Vincristine—colon cancer	0.0273	0.056	CbGbCtD
Haloperidol—CYP1A2—Fluorouracil—colon cancer	0.0223	0.0457	CbGbCtD
Haloperidol—ABCB1—Irinotecan—colon cancer	0.0203	0.0417	CbGbCtD
Haloperidol—CYP2C9—Fluorouracil—colon cancer	0.0201	0.0412	CbGbCtD
Haloperidol—ABCB1—Vincristine—colon cancer	0.0178	0.0364	CbGbCtD
Haloperidol—CYP3A4—Irinotecan—colon cancer	0.0122	0.025	CbGbCtD
Haloperidol—ABCB1—Methotrexate—colon cancer	0.0108	0.022	CbGbCtD
Haloperidol—CYP3A4—Vincristine—colon cancer	0.0106	0.0218	CbGbCtD
Haloperidol—HTR2A—myenteric nerve plexus—colon cancer	0.00495	0.0755	CbGeAlD
Haloperidol—HTR2A—vein—colon cancer	0.00319	0.0486	CbGeAlD
Haloperidol—HTR1B—blood vessel—colon cancer	0.0021	0.0321	CbGeAlD
Haloperidol—HTR1D—blood vessel—colon cancer	0.00204	0.0311	CbGeAlD
Haloperidol—EBP—liver—colon cancer	0.00194	0.0296	CbGeAlD
Haloperidol—UGT1A9—renal system—colon cancer	0.00193	0.0294	CbGeAlD
Haloperidol—UGT1A9—digestive system—colon cancer	0.00158	0.0241	CbGeAlD
Haloperidol—H1F0—embryo—colon cancer	0.00157	0.0239	CbGeAlD
Haloperidol—CBR1—renal system—colon cancer	0.00145	0.0221	CbGeAlD
Haloperidol—H1F0—smooth muscle tissue—colon cancer	0.00123	0.0188	CbGeAlD
Haloperidol—CBR1—lymphoid tissue—colon cancer	0.0012	0.0184	CbGeAlD
Haloperidol—CBR1—digestive system—colon cancer	0.00119	0.0181	CbGeAlD
Haloperidol—H1F0—renal system—colon cancer	0.00119	0.0181	CbGeAlD
Haloperidol—UGT1A9—liver—colon cancer	0.00118	0.0179	CbGeAlD
Haloperidol—HTR2A—endothelium—colon cancer	0.0011	0.0167	CbGeAlD
Haloperidol—CBR1—bone marrow—colon cancer	0.0011	0.0167	CbGeAlD
Haloperidol—CBR1—vagina—colon cancer	0.00105	0.016	CbGeAlD
Haloperidol—HTR2A—blood vessel—colon cancer	0.00101	0.0154	CbGeAlD
Haloperidol—H1F0—lymphoid tissue—colon cancer	0.000986	0.015	CbGeAlD
Haloperidol—CYP3A7—liver—colon cancer	0.000978	0.0149	CbGeAlD
Haloperidol—H1F0—digestive system—colon cancer	0.000974	0.0149	CbGeAlD
Haloperidol—H1F0—bone marrow—colon cancer	0.000897	0.0137	CbGeAlD
Haloperidol—SIGMAR1—smooth muscle tissue—colon cancer	0.000891	0.0136	CbGeAlD
Haloperidol—HTR2B—smooth muscle tissue—colon cancer	0.000889	0.0136	CbGeAlD
Haloperidol—CBR1—liver—colon cancer	0.000885	0.0135	CbGeAlD
Haloperidol—H1F0—vagina—colon cancer	0.00086	0.0131	CbGeAlD
Haloperidol—CYP3A7-CYP3A51P—liver—colon cancer	0.000832	0.0127	CbGeAlD
Haloperidol—H1F0—liver—colon cancer	0.000725	0.0111	CbGeAlD
Haloperidol—HTR2B—digestive system—colon cancer	0.000702	0.0107	CbGeAlD
Haloperidol—KCNH2—renal system—colon cancer	0.000682	0.0104	CbGeAlD
Haloperidol—CBR1—lymph node—colon cancer	0.000679	0.0104	CbGeAlD
Haloperidol—ABCB1—blood vessel—colon cancer	0.000663	0.0101	CbGeAlD
Haloperidol—SIGMAR1—bone marrow—colon cancer	0.000648	0.00989	CbGeAlD
Haloperidol—CYP1A1—epithelium—colon cancer	0.000621	0.00948	CbGeAlD
Haloperidol—SIGMAR1—vagina—colon cancer	0.000621	0.00947	CbGeAlD
Haloperidol—HTR2B—vagina—colon cancer	0.00062	0.00945	CbGeAlD
Haloperidol—HTR2A—embryo—colon cancer	0.000603	0.00921	CbGeAlD
Haloperidol—Dysphagia—Fluorouracil—colon cancer	0.000593	0.00466	CcSEcCtD
Haloperidol—HRH1—epithelium—colon cancer	0.00059	0.00899	CbGeAlD
Haloperidol—CYP2C19—digestive system—colon cancer	0.000587	0.00895	CbGeAlD
Haloperidol—Erectile dysfunction—Vincristine—colon cancer	0.000586	0.0046	CcSEcCtD
Haloperidol—CYP1A2—renal system—colon cancer	0.000584	0.00891	CbGeAlD
Haloperidol—Photosensitivity reaction—Vincristine—colon cancer	0.00058	0.00456	CcSEcCtD
Haloperidol—Neutropenia—Irinotecan—colon cancer	0.000579	0.00455	CcSEcCtD
Haloperidol—CYP1A1—renal system—colon cancer	0.000576	0.00879	CbGeAlD
Haloperidol—Weight decreased—Vincristine—colon cancer	0.000575	0.00452	CcSEcCtD
Haloperidol—HRH1—smooth muscle tissue—colon cancer	0.000568	0.00867	CbGeAlD
Haloperidol—Depression—Vincristine—colon cancer	0.000565	0.00444	CcSEcCtD
Haloperidol—CYP3A5—renal system—colon cancer	0.000563	0.0086	CbGeAlD
Haloperidol—Pancytopenia—Fluorouracil—colon cancer	0.000563	0.00443	CcSEcCtD
Haloperidol—Weight decreased—Irinotecan—colon cancer	0.00056	0.0044	CcSEcCtD
Haloperidol—H1F0—lymph node—colon cancer	0.000556	0.00848	CbGeAlD
Haloperidol—Hepatic function abnormal—Capecitabine—colon cancer	0.000549	0.00431	CcSEcCtD
Haloperidol—Musculoskeletal stiffness—Methotrexate—colon cancer	0.000548	0.00431	CcSEcCtD
Haloperidol—Photosensitivity—Capecitabine—colon cancer	0.000546	0.00429	CcSEcCtD
Haloperidol—Photosensitivity reaction—Fluorouracil—colon cancer	0.000541	0.00425	CcSEcCtD
Haloperidol—Jaundice—Irinotecan—colon cancer	0.000538	0.00423	CcSEcCtD
Haloperidol—SIGMAR1—liver—colon cancer	0.000524	0.00799	CbGeAlD
Haloperidol—CYP2C19—vagina—colon cancer	0.000518	0.0079	CbGeAlD
Haloperidol—Libido decreased—Capecitabine—colon cancer	0.000517	0.00406	CcSEcCtD
Haloperidol—KCNH2—bone marrow—colon cancer	0.000516	0.00787	CbGeAlD
Haloperidol—Dermatitis exfoliative—Capecitabine—colon cancer	0.000508	0.00399	CcSEcCtD
Haloperidol—Hallucination—Vincristine—colon cancer	0.000506	0.00398	CcSEcCtD
Haloperidol—Urinary tract disorder—Vincristine—colon cancer	0.000503	0.00395	CcSEcCtD
Haloperidol—Connective tissue disorder—Vincristine—colon cancer	0.0005	0.00393	CcSEcCtD
Haloperidol—Urethral disorder—Vincristine—colon cancer	0.000499	0.00392	CcSEcCtD
Haloperidol—KCNH2—vagina—colon cancer	0.000494	0.00754	CbGeAlD
Haloperidol—Agranulocytosis—Fluorouracil—colon cancer	0.000494	0.00388	CcSEcCtD
Haloperidol—HTR2A—epithelium—colon cancer	0.000492	0.00751	CbGeAlD
Haloperidol—Lethargy—Capecitabine—colon cancer	0.000489	0.00385	CcSEcCtD
Haloperidol—Connective tissue disorder—Irinotecan—colon cancer	0.000487	0.00383	CcSEcCtD
Haloperidol—Hyponatraemia—Capecitabine—colon cancer	0.000482	0.00378	CcSEcCtD
Haloperidol—CYP1A2—digestive system—colon cancer	0.000479	0.00731	CbGeAlD
Haloperidol—Visual impairment—Irinotecan—colon cancer	0.000478	0.00375	CcSEcCtD
Haloperidol—Disturbance in sexual arousal—Capecitabine—colon cancer	0.000476	0.00374	CcSEcCtD
Haloperidol—HTR2A—smooth muscle tissue—colon cancer	0.000474	0.00724	CbGeAlD
Haloperidol—CYP1A1—digestive system—colon cancer	0.000473	0.00721	CbGeAlD
Haloperidol—Cardiac disorder—Vincristine—colon cancer	0.000472	0.00371	CcSEcCtD
Haloperidol—Face oedema—Capecitabine—colon cancer	0.000463	0.00364	CcSEcCtD
Haloperidol—CYP3A5—digestive system—colon cancer	0.000462	0.00705	CbGeAlD
Haloperidol—Angiopathy—Vincristine—colon cancer	0.000462	0.00363	CcSEcCtD
Haloperidol—Cardiac disorder—Irinotecan—colon cancer	0.00046	0.00362	CcSEcCtD
Haloperidol—Mediastinal disorder—Vincristine—colon cancer	0.000459	0.0036	CcSEcCtD
Haloperidol—HTR2A—renal system—colon cancer	0.000457	0.00697	CbGeAlD
Haloperidol—Cardiac arrest—Capecitabine—colon cancer	0.000456	0.00358	CcSEcCtD
Haloperidol—Urinary retention—Capecitabine—colon cancer	0.000456	0.00358	CcSEcCtD
Haloperidol—CYP2C9—digestive system—colon cancer	0.000455	0.00694	CbGeAlD
Haloperidol—Alopecia—Vincristine—colon cancer	0.00045	0.00353	CcSEcCtD
Haloperidol—Angiopathy—Irinotecan—colon cancer	0.00045	0.00353	CcSEcCtD
Haloperidol—HRH1—digestive system—colon cancer	0.000449	0.00684	CbGeAlD
Haloperidol—Immune system disorder—Irinotecan—colon cancer	0.000448	0.00352	CcSEcCtD
Haloperidol—Mediastinal disorder—Irinotecan—colon cancer	0.000447	0.00351	CcSEcCtD
Haloperidol—Mental disorder—Vincristine—colon cancer	0.000446	0.0035	CcSEcCtD
Haloperidol—Liver function test abnormal—Capecitabine—colon cancer	0.000443	0.00348	CcSEcCtD
Haloperidol—Gynaecomastia—Methotrexate—colon cancer	0.00044	0.00346	CcSEcCtD
Haloperidol—Alopecia—Irinotecan—colon cancer	0.000438	0.00344	CcSEcCtD
Haloperidol—Orthostatic hypotension—Capecitabine—colon cancer	0.000438	0.00344	CcSEcCtD
Haloperidol—CYP2C19—liver—colon cancer	0.000437	0.00667	CbGeAlD
Haloperidol—Breast disorder—Capecitabine—colon cancer	0.000433	0.00341	CcSEcCtD
Haloperidol—CYP3A4—renal system—colon cancer	0.000423	0.00645	CbGeAlD
Haloperidol—Alopecia—Fluorouracil—colon cancer	0.00042	0.0033	CcSEcCtD
Haloperidol—CYP1A1—vagina—colon cancer	0.000417	0.00637	CbGeAlD
Haloperidol—CYP2D6—renal system—colon cancer	0.000416	0.00635	CbGeAlD
Haloperidol—Muscle spasms—Irinotecan—colon cancer	0.000415	0.00326	CcSEcCtD
Haloperidol—Dysphagia—Capecitabine—colon cancer	0.000415	0.00326	CcSEcCtD
Haloperidol—Anaemia—Vincristine—colon cancer	0.00041	0.00322	CcSEcCtD
Haloperidol—CYP3A5—vagina—colon cancer	0.000408	0.00623	CbGeAlD
Haloperidol—Bronchospasm—Capecitabine—colon cancer	0.000408	0.0032	CcSEcCtD
Haloperidol—Agitation—Vincristine—colon cancer	0.000407	0.0032	CcSEcCtD
Haloperidol—Photosensitivity—Methotrexate—colon cancer	0.000407	0.0032	CcSEcCtD
Haloperidol—Sweating increased—Capecitabine—colon cancer	0.000404	0.00317	CcSEcCtD
Haloperidol—SIGMAR1—lymph node—colon cancer	0.000402	0.00613	CbGeAlD
Haloperidol—HTR2B—lymph node—colon cancer	0.000401	0.00611	CbGeAlD
Haloperidol—Anaemia—Irinotecan—colon cancer	0.000399	0.00313	CcSEcCtD
Haloperidol—Vertigo—Vincristine—colon cancer	0.000398	0.00313	CcSEcCtD
Haloperidol—Leukopenia—Vincristine—colon cancer	0.000397	0.00312	CcSEcCtD
Haloperidol—HRH1—vagina—colon cancer	0.000396	0.00604	CbGeAlD
Haloperidol—ABCB1—embryo—colon cancer	0.000395	0.00603	CbGeAlD
Haloperidol—Pancytopenia—Capecitabine—colon cancer	0.000394	0.00309	CcSEcCtD
Haloperidol—Vision blurred—Fluorouracil—colon cancer	0.00039	0.00306	CcSEcCtD
Haloperidol—Vertigo—Irinotecan—colon cancer	0.000388	0.00305	CcSEcCtD
Haloperidol—Neutropenia—Capecitabine—colon cancer	0.000388	0.00305	CcSEcCtD
Haloperidol—Leukopenia—Irinotecan—colon cancer	0.000386	0.00304	CcSEcCtD
Haloperidol—Convulsion—Vincristine—colon cancer	0.000384	0.00302	CcSEcCtD
Haloperidol—Hypertension—Vincristine—colon cancer	0.000383	0.00301	CcSEcCtD
Haloperidol—Anaemia—Fluorouracil—colon cancer	0.000382	0.003	CcSEcCtD
Haloperidol—Dermatitis exfoliative—Methotrexate—colon cancer	0.000378	0.00297	CcSEcCtD
Haloperidol—Photosensitivity reaction—Capecitabine—colon cancer	0.000378	0.00297	CcSEcCtD
Haloperidol—Weight increased—Capecitabine—colon cancer	0.000377	0.00296	CcSEcCtD
Haloperidol—Visual disturbance—Methotrexate—colon cancer	0.000377	0.00296	CcSEcCtD
Haloperidol—Weight decreased—Capecitabine—colon cancer	0.000375	0.00295	CcSEcCtD
Haloperidol—HTR2A—digestive system—colon cancer	0.000375	0.00572	CbGeAlD
Haloperidol—Hyperglycaemia—Capecitabine—colon cancer	0.000374	0.00294	CcSEcCtD
Haloperidol—Hypertension—Irinotecan—colon cancer	0.000373	0.00293	CcSEcCtD
Haloperidol—Leukopenia—Fluorouracil—colon cancer	0.00037	0.00291	CcSEcCtD
Haloperidol—Depression—Capecitabine—colon cancer	0.000369	0.0029	CcSEcCtD
Haloperidol—Lethargy—Methotrexate—colon cancer	0.000364	0.00286	CcSEcCtD
Haloperidol—Oedema—Vincristine—colon cancer	0.000362	0.00284	CcSEcCtD
Haloperidol—Anaphylactic shock—Vincristine—colon cancer	0.000362	0.00284	CcSEcCtD
Haloperidol—Jaundice—Capecitabine—colon cancer	0.00036	0.00283	CcSEcCtD
Haloperidol—Convulsion—Fluorouracil—colon cancer	0.000358	0.00281	CcSEcCtD
Haloperidol—CYP1A2—liver—colon cancer	0.000357	0.00545	CbGeAlD
Haloperidol—Confusional state—Irinotecan—colon cancer	0.000355	0.00279	CcSEcCtD
Haloperidol—Nervous system disorder—Vincristine—colon cancer	0.000355	0.00279	CcSEcCtD
Haloperidol—Thrombocytopenia—Vincristine—colon cancer	0.000354	0.00278	CcSEcCtD
Haloperidol—Anaphylactic shock—Irinotecan—colon cancer	0.000352	0.00277	CcSEcCtD
Haloperidol—Oedema—Irinotecan—colon cancer	0.000352	0.00277	CcSEcCtD
Haloperidol—CYP1A1—liver—colon cancer	0.000352	0.00537	CbGeAlD
Haloperidol—Hyperhidrosis—Vincristine—colon cancer	0.00035	0.00275	CcSEcCtD
Haloperidol—Hepatobiliary disease—Capecitabine—colon cancer	0.00035	0.00275	CcSEcCtD
Haloperidol—CYP3A4—digestive system—colon cancer	0.000347	0.00529	CbGeAlD
Haloperidol—Nervous system disorder—Irinotecan—colon cancer	0.000345	0.00271	CcSEcCtD
Haloperidol—Agranulocytosis—Capecitabine—colon cancer	0.000345	0.00271	CcSEcCtD
Haloperidol—Thrombocytopenia—Irinotecan—colon cancer	0.000345	0.00271	CcSEcCtD
Haloperidol—Anorexia—Vincristine—colon cancer	0.000345	0.00271	CcSEcCtD
Haloperidol—CYP3A5—liver—colon cancer	0.000344	0.00525	CbGeAlD
Haloperidol—CYP2D6—digestive system—colon cancer	0.000341	0.00521	CbGeAlD
Haloperidol—Hyperhidrosis—Irinotecan—colon cancer	0.00034	0.00268	CcSEcCtD
Haloperidol—Confusional state—Fluorouracil—colon cancer	0.00034	0.00267	CcSEcCtD
Haloperidol—CYP2C9—liver—colon cancer	0.000339	0.00517	CbGeAlD
Haloperidol—Hypotension—Vincristine—colon cancer	0.000338	0.00266	CcSEcCtD
Haloperidol—Anaphylactic shock—Fluorouracil—colon cancer	0.000337	0.00265	CcSEcCtD
Haloperidol—Oedema—Fluorouracil—colon cancer	0.000337	0.00265	CcSEcCtD
Haloperidol—Anorexia—Irinotecan—colon cancer	0.000336	0.00264	CcSEcCtD
Haloperidol—Hepatitis—Capecitabine—colon cancer	0.000332	0.00261	CcSEcCtD
Haloperidol—HTR2A—vagina—colon cancer	0.000331	0.00505	CbGeAlD
Haloperidol—Nervous system disorder—Fluorouracil—colon cancer	0.000331	0.0026	CcSEcCtD
Haloperidol—Thrombocytopenia—Fluorouracil—colon cancer	0.00033	0.0026	CcSEcCtD
Haloperidol—Liver function test abnormal—Methotrexate—colon cancer	0.00033	0.00259	CcSEcCtD
Haloperidol—Tachycardia—Fluorouracil—colon cancer	0.000329	0.00259	CcSEcCtD
Haloperidol—Hypotension—Irinotecan—colon cancer	0.000329	0.00259	CcSEcCtD
Haloperidol—Urinary tract disorder—Capecitabine—colon cancer	0.000328	0.00257	CcSEcCtD
Haloperidol—Insomnia—Vincristine—colon cancer	0.000327	0.00257	CcSEcCtD
Haloperidol—Connective tissue disorder—Capecitabine—colon cancer	0.000326	0.00256	CcSEcCtD
Haloperidol—Urethral disorder—Capecitabine—colon cancer	0.000325	0.00256	CcSEcCtD
Haloperidol—ABCB1—epithelium—colon cancer	0.000323	0.00492	CbGeAlD
Haloperidol—Breast disorder—Methotrexate—colon cancer	0.000323	0.00254	CcSEcCtD
Haloperidol—Anorexia—Fluorouracil—colon cancer	0.000322	0.00253	CcSEcCtD
Haloperidol—Visual impairment—Capecitabine—colon cancer	0.00032	0.00251	CcSEcCtD
Haloperidol—KCNH2—lymph node—colon cancer	0.00032	0.00488	CbGeAlD
Haloperidol—Insomnia—Irinotecan—colon cancer	0.000319	0.0025	CcSEcCtD
Haloperidol—Hypotension—Fluorouracil—colon cancer	0.000315	0.00248	CcSEcCtD
Haloperidol—Decreased appetite—Vincristine—colon cancer	0.000314	0.00247	CcSEcCtD
Haloperidol—Dyspnoea—Irinotecan—colon cancer	0.000314	0.00247	CcSEcCtD
Haloperidol—Somnolence—Irinotecan—colon cancer	0.000313	0.00246	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Vincristine—colon cancer	0.000312	0.00245	CcSEcCtD
Haloperidol—Eye disorder—Capecitabine—colon cancer	0.00031	0.00244	CcSEcCtD
Haloperidol—Dyspepsia—Irinotecan—colon cancer	0.00031	0.00244	CcSEcCtD
Haloperidol—Constipation—Vincristine—colon cancer	0.000309	0.00243	CcSEcCtD
Haloperidol—Cardiac disorder—Capecitabine—colon cancer	0.000308	0.00242	CcSEcCtD
Haloperidol—Decreased appetite—Irinotecan—colon cancer	0.000306	0.00241	CcSEcCtD
Haloperidol—Insomnia—Fluorouracil—colon cancer	0.000305	0.0024	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Irinotecan—colon cancer	0.000304	0.00239	CcSEcCtD
Haloperidol—Constipation—Irinotecan—colon cancer	0.000301	0.00237	CcSEcCtD
Haloperidol—Angiopathy—Capecitabine—colon cancer	0.000301	0.00237	CcSEcCtD
Haloperidol—Dyspnoea—Fluorouracil—colon cancer	0.000301	0.00236	CcSEcCtD
Haloperidol—Somnolence—Fluorouracil—colon cancer	0.0003	0.00236	CcSEcCtD
Haloperidol—Immune system disorder—Capecitabine—colon cancer	0.0003	0.00235	CcSEcCtD
Haloperidol—ABCB1—renal system—colon cancer	0.000299	0.00457	CbGeAlD
Haloperidol—Mediastinal disorder—Capecitabine—colon cancer	0.000299	0.00235	CcSEcCtD
Haloperidol—Dyspepsia—Fluorouracil—colon cancer	0.000297	0.00233	CcSEcCtD
Haloperidol—Decreased appetite—Fluorouracil—colon cancer	0.000293	0.0023	CcSEcCtD
Haloperidol—Alopecia—Capecitabine—colon cancer	0.000293	0.0023	CcSEcCtD
Haloperidol—Pancytopenia—Methotrexate—colon cancer	0.000293	0.0023	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000291	0.00229	CcSEcCtD
Haloperidol—Mental disorder—Capecitabine—colon cancer	0.000291	0.00228	CcSEcCtD
Haloperidol—Feeling abnormal—Irinotecan—colon cancer	0.00029	0.00228	CcSEcCtD
Haloperidol—Malnutrition—Capecitabine—colon cancer	0.000289	0.00227	CcSEcCtD
Haloperidol—Neutropenia—Methotrexate—colon cancer	0.000289	0.00227	CcSEcCtD
Haloperidol—Body temperature increased—Vincristine—colon cancer	0.000286	0.00225	CcSEcCtD
Haloperidol—Erectile dysfunction—Methotrexate—colon cancer	0.000284	0.00223	CcSEcCtD
Haloperidol—Photosensitivity reaction—Methotrexate—colon cancer	0.000282	0.00221	CcSEcCtD
Haloperidol—HTR2A—liver—colon cancer	0.000279	0.00426	CbGeAlD
Haloperidol—Body temperature increased—Irinotecan—colon cancer	0.000278	0.00219	CcSEcCtD
Haloperidol—Feeling abnormal—Fluorouracil—colon cancer	0.000278	0.00218	CcSEcCtD
Haloperidol—Muscle spasms—Capecitabine—colon cancer	0.000278	0.00218	CcSEcCtD
Haloperidol—Drowsiness—Methotrexate—colon cancer	0.000275	0.00216	CcSEcCtD
Haloperidol—Depression—Methotrexate—colon cancer	0.000274	0.00216	CcSEcCtD
Haloperidol—Vision blurred—Capecitabine—colon cancer	0.000272	0.00214	CcSEcCtD
Haloperidol—Tremor—Capecitabine—colon cancer	0.000271	0.00213	CcSEcCtD
Haloperidol—CYP1A1—lymph node—colon cancer	0.00027	0.00412	CbGeAlD
Haloperidol—Urticaria—Fluorouracil—colon cancer	0.000268	0.00211	CcSEcCtD
Haloperidol—Anaemia—Capecitabine—colon cancer	0.000267	0.0021	CcSEcCtD
Haloperidol—Body temperature increased—Fluorouracil—colon cancer	0.000267	0.0021	CcSEcCtD
Haloperidol—Hypersensitivity—Vincristine—colon cancer	0.000266	0.00209	CcSEcCtD
Haloperidol—Hepatobiliary disease—Methotrexate—colon cancer	0.00026	0.00204	CcSEcCtD
Haloperidol—Vertigo—Capecitabine—colon cancer	0.000259	0.00204	CcSEcCtD
Haloperidol—Hypersensitivity—Irinotecan—colon cancer	0.000259	0.00204	CcSEcCtD
Haloperidol—Leukopenia—Capecitabine—colon cancer	0.000259	0.00203	CcSEcCtD
Haloperidol—CYP3A4—liver—colon cancer	0.000258	0.00394	CbGeAlD
Haloperidol—Agranulocytosis—Methotrexate—colon cancer	0.000257	0.00202	CcSEcCtD
Haloperidol—HRH1—lymph node—colon cancer	0.000256	0.00391	CbGeAlD
Haloperidol—CYP2D6—liver—colon cancer	0.000254	0.00388	CbGeAlD
Haloperidol—Hypertension—Capecitabine—colon cancer	0.000249	0.00196	CcSEcCtD
Haloperidol—ABCB1—lymphoid tissue—colon cancer	0.000249	0.00379	CbGeAlD
Haloperidol—Hypersensitivity—Fluorouracil—colon cancer	0.000249	0.00195	CcSEcCtD
Haloperidol—Diarrhoea—Vincristine—colon cancer	0.000247	0.00194	CcSEcCtD
Haloperidol—Hepatitis—Methotrexate—colon cancer	0.000247	0.00194	CcSEcCtD
Haloperidol—ABCB1—digestive system—colon cancer	0.000245	0.00375	CbGeAlD
Haloperidol—Anxiety—Capecitabine—colon cancer	0.000245	0.00193	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000244	0.00192	CcSEcCtD
Haloperidol—Urinary tract disorder—Methotrexate—colon cancer	0.000244	0.00192	CcSEcCtD
Haloperidol—Urethral disorder—Methotrexate—colon cancer	0.000242	0.0019	CcSEcCtD
Haloperidol—Diarrhoea—Irinotecan—colon cancer	0.000241	0.00189	CcSEcCtD
Haloperidol—Dry mouth—Capecitabine—colon cancer	0.00024	0.00189	CcSEcCtD
Haloperidol—Dizziness—Vincristine—colon cancer	0.000239	0.00188	CcSEcCtD
Haloperidol—Pruritus—Fluorouracil—colon cancer	0.000239	0.00188	CcSEcCtD
Haloperidol—Visual impairment—Methotrexate—colon cancer	0.000238	0.00187	CcSEcCtD
Haloperidol—Confusional state—Capecitabine—colon cancer	0.000238	0.00187	CcSEcCtD
Haloperidol—Oedema—Capecitabine—colon cancer	0.000236	0.00185	CcSEcCtD
Haloperidol—Dizziness—Irinotecan—colon cancer	0.000233	0.00183	CcSEcCtD
Haloperidol—Nervous system disorder—Capecitabine—colon cancer	0.000231	0.00182	CcSEcCtD
Haloperidol—Eye disorder—Methotrexate—colon cancer	0.000231	0.00181	CcSEcCtD
Haloperidol—Diarrhoea—Fluorouracil—colon cancer	0.000231	0.00181	CcSEcCtD
Haloperidol—Thrombocytopenia—Capecitabine—colon cancer	0.000231	0.00181	CcSEcCtD
Haloperidol—Tachycardia—Capecitabine—colon cancer	0.00023	0.00181	CcSEcCtD
Haloperidol—Vomiting—Vincristine—colon cancer	0.00023	0.00181	CcSEcCtD
Haloperidol—Cardiac disorder—Methotrexate—colon cancer	0.000229	0.0018	CcSEcCtD
Haloperidol—Skin disorder—Capecitabine—colon cancer	0.000229	0.0018	CcSEcCtD
Haloperidol—Rash—Vincristine—colon cancer	0.000228	0.00179	CcSEcCtD
Haloperidol—Hyperhidrosis—Capecitabine—colon cancer	0.000228	0.00179	CcSEcCtD
Haloperidol—Dermatitis—Vincristine—colon cancer	0.000228	0.00179	CcSEcCtD
Haloperidol—Headache—Vincristine—colon cancer	0.000227	0.00178	CcSEcCtD
Haloperidol—ABCB1—bone marrow—colon cancer	0.000226	0.00345	CbGeAlD
Haloperidol—Anorexia—Capecitabine—colon cancer	0.000225	0.00177	CcSEcCtD
Haloperidol—Angiopathy—Methotrexate—colon cancer	0.000224	0.00176	CcSEcCtD
Haloperidol—Vomiting—Irinotecan—colon cancer	0.000224	0.00176	CcSEcCtD
Haloperidol—Immune system disorder—Methotrexate—colon cancer	0.000223	0.00175	CcSEcCtD
Haloperidol—Dizziness—Fluorouracil—colon cancer	0.000223	0.00175	CcSEcCtD
Haloperidol—Mediastinal disorder—Methotrexate—colon cancer	0.000223	0.00175	CcSEcCtD
Haloperidol—Rash—Irinotecan—colon cancer	0.000222	0.00174	CcSEcCtD
Haloperidol—Dermatitis—Irinotecan—colon cancer	0.000222	0.00174	CcSEcCtD
Haloperidol—Headache—Irinotecan—colon cancer	0.000221	0.00173	CcSEcCtD
Haloperidol—Hypotension—Capecitabine—colon cancer	0.00022	0.00173	CcSEcCtD
Haloperidol—Alopecia—Methotrexate—colon cancer	0.000218	0.00172	CcSEcCtD
Haloperidol—ABCB1—vagina—colon cancer	0.000217	0.00331	CbGeAlD
Haloperidol—Mental disorder—Methotrexate—colon cancer	0.000216	0.0017	CcSEcCtD
Haloperidol—Malnutrition—Methotrexate—colon cancer	0.000215	0.00169	CcSEcCtD
Haloperidol—Nausea—Vincristine—colon cancer	0.000215	0.00169	CcSEcCtD
Haloperidol—Vomiting—Fluorouracil—colon cancer	0.000214	0.00169	CcSEcCtD
Haloperidol—Insomnia—Capecitabine—colon cancer	0.000213	0.00168	CcSEcCtD
Haloperidol—Rash—Fluorouracil—colon cancer	0.000213	0.00167	CcSEcCtD
Haloperidol—Dermatitis—Fluorouracil—colon cancer	0.000212	0.00167	CcSEcCtD
Haloperidol—Headache—Fluorouracil—colon cancer	0.000211	0.00166	CcSEcCtD
Haloperidol—Dyspnoea—Capecitabine—colon cancer	0.00021	0.00165	CcSEcCtD
Haloperidol—Nausea—Irinotecan—colon cancer	0.000209	0.00164	CcSEcCtD
Haloperidol—Dyspepsia—Capecitabine—colon cancer	0.000207	0.00163	CcSEcCtD
Haloperidol—Decreased appetite—Capecitabine—colon cancer	0.000205	0.00161	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Capecitabine—colon cancer	0.000204	0.0016	CcSEcCtD
Haloperidol—Vision blurred—Methotrexate—colon cancer	0.000203	0.00159	CcSEcCtD
Haloperidol—Constipation—Capecitabine—colon cancer	0.000202	0.00158	CcSEcCtD
Haloperidol—Nausea—Fluorouracil—colon cancer	0.0002	0.00157	CcSEcCtD
Haloperidol—Anaemia—Methotrexate—colon cancer	0.000199	0.00156	CcSEcCtD
Haloperidol—Feeling abnormal—Capecitabine—colon cancer	0.000194	0.00153	CcSEcCtD
Haloperidol—Vertigo—Methotrexate—colon cancer	0.000193	0.00152	CcSEcCtD
Haloperidol—Leukopenia—Methotrexate—colon cancer	0.000192	0.00151	CcSEcCtD
Haloperidol—Urticaria—Capecitabine—colon cancer	0.000187	0.00147	CcSEcCtD
Haloperidol—Body temperature increased—Capecitabine—colon cancer	0.000186	0.00146	CcSEcCtD
Haloperidol—Convulsion—Methotrexate—colon cancer	0.000186	0.00146	CcSEcCtD
Haloperidol—ABCB1—liver—colon cancer	0.000183	0.00279	CbGeAlD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000182	0.00143	CcSEcCtD
Haloperidol—Confusional state—Methotrexate—colon cancer	0.000177	0.00139	CcSEcCtD
Haloperidol—Anaphylactic shock—Methotrexate—colon cancer	0.000175	0.00138	CcSEcCtD
Haloperidol—Hypersensitivity—Capecitabine—colon cancer	0.000174	0.00136	CcSEcCtD
Haloperidol—Nervous system disorder—Methotrexate—colon cancer	0.000172	0.00135	CcSEcCtD
Haloperidol—Thrombocytopenia—Methotrexate—colon cancer	0.000172	0.00135	CcSEcCtD
Haloperidol—Skin disorder—Methotrexate—colon cancer	0.00017	0.00134	CcSEcCtD
Haloperidol—Hyperhidrosis—Methotrexate—colon cancer	0.00017	0.00133	CcSEcCtD
Haloperidol—Anorexia—Methotrexate—colon cancer	0.000167	0.00131	CcSEcCtD
Haloperidol—Pruritus—Capecitabine—colon cancer	0.000167	0.00131	CcSEcCtD
Haloperidol—Hypotension—Methotrexate—colon cancer	0.000164	0.00129	CcSEcCtD
Haloperidol—Diarrhoea—Capecitabine—colon cancer	0.000161	0.00127	CcSEcCtD
Haloperidol—Insomnia—Methotrexate—colon cancer	0.000159	0.00125	CcSEcCtD
Haloperidol—Dyspnoea—Methotrexate—colon cancer	0.000156	0.00123	CcSEcCtD
Haloperidol—Somnolence—Methotrexate—colon cancer	0.000156	0.00123	CcSEcCtD
Haloperidol—Dizziness—Capecitabine—colon cancer	0.000156	0.00122	CcSEcCtD
Haloperidol—Dyspepsia—Methotrexate—colon cancer	0.000154	0.00121	CcSEcCtD
Haloperidol—Decreased appetite—Methotrexate—colon cancer	0.000153	0.0012	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Methotrexate—colon cancer	0.000151	0.00119	CcSEcCtD
Haloperidol—Vomiting—Capecitabine—colon cancer	0.00015	0.00118	CcSEcCtD
Haloperidol—Rash—Capecitabine—colon cancer	0.000149	0.00117	CcSEcCtD
Haloperidol—Dermatitis—Capecitabine—colon cancer	0.000148	0.00117	CcSEcCtD
Haloperidol—Headache—Capecitabine—colon cancer	0.000148	0.00116	CcSEcCtD
Haloperidol—Feeling abnormal—Methotrexate—colon cancer	0.000145	0.00114	CcSEcCtD
Haloperidol—ABCB1—lymph node—colon cancer	0.00014	0.00214	CbGeAlD
Haloperidol—Nausea—Capecitabine—colon cancer	0.00014	0.0011	CcSEcCtD
Haloperidol—Urticaria—Methotrexate—colon cancer	0.000139	0.0011	CcSEcCtD
Haloperidol—Body temperature increased—Methotrexate—colon cancer	0.000139	0.00109	CcSEcCtD
Haloperidol—Hypersensitivity—Methotrexate—colon cancer	0.000129	0.00102	CcSEcCtD
Haloperidol—Pruritus—Methotrexate—colon cancer	0.000124	0.000976	CcSEcCtD
Haloperidol—Diarrhoea—Methotrexate—colon cancer	0.00012	0.000943	CcSEcCtD
Haloperidol—Dizziness—Methotrexate—colon cancer	0.000116	0.000912	CcSEcCtD
Haloperidol—Vomiting—Methotrexate—colon cancer	0.000112	0.000877	CcSEcCtD
Haloperidol—Rash—Methotrexate—colon cancer	0.000111	0.000869	CcSEcCtD
Haloperidol—Dermatitis—Methotrexate—colon cancer	0.000111	0.000869	CcSEcCtD
Haloperidol—Headache—Methotrexate—colon cancer	0.00011	0.000864	CcSEcCtD
Haloperidol—Nausea—Methotrexate—colon cancer	0.000104	0.000819	CcSEcCtD
Haloperidol—DRD1—Signaling by GPCR—PIK3CA—colon cancer	6e-06	0.000202	CbGpPWpGaD
Haloperidol—DRD4—GPCR downstream signaling—AKT1—colon cancer	6e-06	0.000202	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—CTNNB1—colon cancer	5.95e-06	0.0002	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—CASP3—colon cancer	5.94e-06	0.0002	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—TYMS—colon cancer	5.92e-06	0.000199	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—PIK3CA—colon cancer	5.92e-06	0.000199	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—PTGS2—colon cancer	5.91e-06	0.000199	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—HRAS—colon cancer	5.89e-06	0.000198	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—CCND1—colon cancer	5.88e-06	0.000198	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—EP300—colon cancer	5.84e-06	0.000196	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—CTNNB1—colon cancer	5.82e-06	0.000196	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—CDKN1A—colon cancer	5.81e-06	0.000195	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—CCND1—colon cancer	5.78e-06	0.000195	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—TYMS—colon cancer	5.78e-06	0.000194	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	5.77e-06	0.000194	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—APC—colon cancer	5.73e-06	0.000193	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—NRAS—colon cancer	5.73e-06	0.000193	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—CTNNB1—colon cancer	5.73e-06	0.000193	CbGpPWpGaD
Haloperidol—HTR2B—GPCR downstream signaling—AKT1—colon cancer	5.73e-06	0.000193	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—CDKN1A—colon cancer	5.69e-06	0.000191	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—CASP3—colon cancer	5.67e-06	0.000191	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—AKT1—colon cancer	5.65e-06	0.00019	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—APC—colon cancer	5.64e-06	0.00019	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—NRAS—colon cancer	5.64e-06	0.00019	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—APC—colon cancer	5.63e-06	0.000189	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—NRAS—colon cancer	5.63e-06	0.000189	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.62e-06	0.000189	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—CDKN1A—colon cancer	5.6e-06	0.000188	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.57e-06	0.000187	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—HRAS—colon cancer	5.55e-06	0.000187	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—ABCB1—colon cancer	5.55e-06	0.000187	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—AKT1—colon cancer	5.54e-06	0.000186	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—EP300—colon cancer	5.53e-06	0.000186	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—CCND1—colon cancer	5.52e-06	0.000186	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—ABCB1—colon cancer	5.5e-06	0.000185	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—HRAS—colon cancer	5.48e-06	0.000184	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—CTNNB1—colon cancer	5.47e-06	0.000184	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—TYMS—colon cancer	5.45e-06	0.000183	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—AKT1—colon cancer	5.45e-06	0.000183	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PPARG—colon cancer	5.43e-06	0.000182	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—EP300—colon cancer	5.41e-06	0.000182	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—TYMS—colon cancer	5.4e-06	0.000182	CbGpPWpGaD
Haloperidol—DRD1—GPCR downstream signaling—AKT1—colon cancer	5.4e-06	0.000182	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—BRAF—colon cancer	5.39e-06	0.000181	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—SRC—colon cancer	5.37e-06	0.000181	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CASP3—colon cancer	5.35e-06	0.00018	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—CDKN1A—colon cancer	5.34e-06	0.00018	CbGpPWpGaD
Haloperidol—DRD3—GPCR downstream signaling—AKT1—colon cancer	5.33e-06	0.000179	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—EP300—colon cancer	5.32e-06	0.000179	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—BRAF—colon cancer	5.3e-06	0.000178	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—BRAF—colon cancer	5.29e-06	0.000178	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CASP3—colon cancer	5.28e-06	0.000177	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—SRC—colon cancer	5.26e-06	0.000177	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—VEGFA—colon cancer	5.23e-06	0.000176	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—EGFR—colon cancer	5.22e-06	0.000176	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CCND1—colon cancer	5.21e-06	0.000175	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—AKT1—colon cancer	5.2e-06	0.000175	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—SRC—colon cancer	5.18e-06	0.000174	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—NRAS—colon cancer	5.17e-06	0.000174	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CTNNB1—colon cancer	5.16e-06	0.000173	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CCND1—colon cancer	5.14e-06	0.000173	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—EGFR—colon cancer	5.14e-06	0.000173	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PPARG—colon cancer	5.13e-06	0.000172	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—EGFR—colon cancer	5.13e-06	0.000172	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—VEGFA—colon cancer	5.12e-06	0.000172	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CTNNB1—colon cancer	5.09e-06	0.000171	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—EP300—colon cancer	5.08e-06	0.000171	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—NRAS—colon cancer	5.06e-06	0.00017	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—VEGFA—colon cancer	5.04e-06	0.00017	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CDKN1A—colon cancer	5.04e-06	0.000169	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—PIK3CA—colon cancer	4.99e-06	0.000168	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—NRAS—colon cancer	4.98e-06	0.000167	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CDKN1A—colon cancer	4.97e-06	0.000167	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—SRC—colon cancer	4.94e-06	0.000166	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—KRAS—colon cancer	4.93e-06	0.000166	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—EP300—colon cancer	4.91e-06	0.000165	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—PIK3CA—colon cancer	4.91e-06	0.000165	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—AKT1—colon cancer	4.9e-06	0.000165	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—PIK3CA—colon cancer	4.9e-06	0.000165	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—KRAS—colon cancer	4.85e-06	0.000163	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—KRAS—colon cancer	4.84e-06	0.000163	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—AKT1—colon cancer	4.84e-06	0.000163	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—MYC—colon cancer	4.82e-06	0.000162	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—VEGFA—colon cancer	4.81e-06	0.000162	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—TGFB1—colon cancer	4.8e-06	0.000162	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.8e-06	0.000161	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—EP300—colon cancer	4.79e-06	0.000161	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—NRAS—colon cancer	4.76e-06	0.00016	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—EP300—colon cancer	4.73e-06	0.000159	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—MYC—colon cancer	4.72e-06	0.000159	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—EGFR—colon cancer	4.71e-06	0.000158	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—TGFB1—colon cancer	4.7e-06	0.000158	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—ABCB1—colon cancer	4.7e-06	0.000158	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—SRC—colon cancer	4.66e-06	0.000157	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—MYC—colon cancer	4.64e-06	0.000156	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—TGFB1—colon cancer	4.63e-06	0.000156	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—TYMS—colon cancer	4.61e-06	0.000155	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—EGFR—colon cancer	4.61e-06	0.000155	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—SRC—colon cancer	4.6e-06	0.000155	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.56e-06	0.000153	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—VEGFA—colon cancer	4.54e-06	0.000153	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—EGFR—colon cancer	4.54e-06	0.000153	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—PIK3CA—colon cancer	4.53e-06	0.000152	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—NRAS—colon cancer	4.48e-06	0.000151	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—VEGFA—colon cancer	4.48e-06	0.000151	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—PIK3CA—colon cancer	4.46e-06	0.00015	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—PIK3CA—colon cancer	4.45e-06	0.00015	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—KRAS—colon cancer	4.45e-06	0.00015	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—MYC—colon cancer	4.43e-06	0.000149	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—NRAS—colon cancer	4.42e-06	0.000149	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—TGFB1—colon cancer	4.42e-06	0.000149	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—KRAS—colon cancer	4.36e-06	0.000146	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—EGFR—colon cancer	4.33e-06	0.000146	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—PIK3CA—colon cancer	4.32e-06	0.000145	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—KRAS—colon cancer	4.29e-06	0.000144	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PTGS2—colon cancer	4.27e-06	0.000144	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PPARG—colon cancer	4.2e-06	0.000141	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—HRAS—colon cancer	4.19e-06	0.000141	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—MYC—colon cancer	4.18e-06	0.00014	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—TGFB1—colon cancer	4.17e-06	0.00014	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.16e-06	0.00014	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—HRAS—colon cancer	4.13e-06	0.000139	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—MYC—colon cancer	4.12e-06	0.000139	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—HRAS—colon cancer	4.12e-06	0.000138	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—TGFB1—colon cancer	4.11e-06	0.000138	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PPARG—colon cancer	4.09e-06	0.000138	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—KRAS—colon cancer	4.09e-06	0.000138	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—PIK3CA—colon cancer	4.09e-06	0.000137	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—EGFR—colon cancer	4.09e-06	0.000137	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—AKT1—colon cancer	4.08e-06	0.000137	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CASP3—colon cancer	4.04e-06	0.000136	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PTGS2—colon cancer	4.03e-06	0.000136	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—EGFR—colon cancer	4.03e-06	0.000136	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—AKT1—colon cancer	4.01e-06	0.000135	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—AKT1—colon cancer	4e-06	0.000135	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—PIK3CA—colon cancer	4e-06	0.000135	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CASP3—colon cancer	3.97e-06	0.000134	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CASP3—colon cancer	3.97e-06	0.000133	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—TP53—colon cancer	3.95e-06	0.000133	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—PIK3CA—colon cancer	3.94e-06	0.000132	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CCND1—colon cancer	3.93e-06	0.000132	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CTNNB1—colon cancer	3.89e-06	0.000131	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—TP53—colon cancer	3.87e-06	0.00013	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CCND1—colon cancer	3.87e-06	0.00013	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CCND1—colon cancer	3.86e-06	0.00013	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—KRAS—colon cancer	3.86e-06	0.00013	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PPARG—colon cancer	3.86e-06	0.00013	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CTNNB1—colon cancer	3.83e-06	0.000129	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PPARG—colon cancer	3.83e-06	0.000129	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CTNNB1—colon cancer	3.82e-06	0.000129	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—TP53—colon cancer	3.81e-06	0.000128	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—KRAS—colon cancer	3.81e-06	0.000128	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CDKN1A—colon cancer	3.8e-06	0.000128	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—HRAS—colon cancer	3.78e-06	0.000127	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—PIK3CA—colon cancer	3.76e-06	0.000126	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CDKN1A—colon cancer	3.74e-06	0.000126	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CDKN1A—colon cancer	3.73e-06	0.000126	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—HRAS—colon cancer	3.7e-06	0.000125	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—AKT1—colon cancer	3.7e-06	0.000124	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—HRAS—colon cancer	3.64e-06	0.000123	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—AKT1—colon cancer	3.64e-06	0.000122	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—TP53—colon cancer	3.64e-06	0.000122	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—AKT1—colon cancer	3.63e-06	0.000122	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—PIK3CA—colon cancer	3.63e-06	0.000122	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ABCB1—colon cancer	3.63e-06	0.000122	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—EP300—colon cancer	3.62e-06	0.000122	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—TYMS—colon cancer	3.56e-06	0.00012	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—EP300—colon cancer	3.56e-06	0.00012	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—EP300—colon cancer	3.55e-06	0.000119	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.55e-06	0.000119	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—EP300—colon cancer	3.55e-06	0.000119	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—PIK3CA—colon cancer	3.55e-06	0.000119	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—AKT1—colon cancer	3.53e-06	0.000119	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—SRC—colon cancer	3.52e-06	0.000118	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—PIK3CA—colon cancer	3.5e-06	0.000118	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—HRAS—colon cancer	3.48e-06	0.000117	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—SRC—colon cancer	3.46e-06	0.000116	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—SRC—colon cancer	3.46e-06	0.000116	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—TP53—colon cancer	3.43e-06	0.000115	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—VEGFA—colon cancer	3.43e-06	0.000115	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—NRAS—colon cancer	3.39e-06	0.000114	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—TP53—colon cancer	3.38e-06	0.000114	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—VEGFA—colon cancer	3.37e-06	0.000113	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—VEGFA—colon cancer	3.37e-06	0.000113	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—EP300—colon cancer	3.35e-06	0.000113	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—AKT1—colon cancer	3.34e-06	0.000112	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—NRAS—colon cancer	3.33e-06	0.000112	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—NRAS—colon cancer	3.32e-06	0.000112	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PTGS2—colon cancer	3.3e-06	0.000111	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—HRAS—colon cancer	3.28e-06	0.00011	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—AKT1—colon cancer	3.27e-06	0.00011	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PPARG—colon cancer	3.27e-06	0.00011	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—HRAS—colon cancer	3.24e-06	0.000109	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PTGS2—colon cancer	3.22e-06	0.000108	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—AKT1—colon cancer	3.22e-06	0.000108	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—MYC—colon cancer	3.15e-06	0.000106	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TGFB1—colon cancer	3.15e-06	0.000106	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—MYC—colon cancer	3.1e-06	0.000104	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—MYC—colon cancer	3.1e-06	0.000104	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TGFB1—colon cancer	3.1e-06	0.000104	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TGFB1—colon cancer	3.09e-06	0.000104	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—EGFR—colon cancer	3.08e-06	0.000104	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—AKT1—colon cancer	3.07e-06	0.000103	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PTGS2—colon cancer	3.04e-06	0.000102	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—EGFR—colon cancer	3.04e-06	0.000102	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—EGFR—colon cancer	3.03e-06	0.000102	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PTGS2—colon cancer	3.01e-06	0.000101	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—AKT1—colon cancer	2.97e-06	9.98e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—KRAS—colon cancer	2.91e-06	9.8e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—AKT1—colon cancer	2.9e-06	9.74e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—KRAS—colon cancer	2.87e-06	9.64e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—KRAS—colon cancer	2.86e-06	9.62e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—AKT1—colon cancer	2.86e-06	9.61e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—EP300—colon cancer	2.74e-06	9.23e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—EP300—colon cancer	2.68e-06	9.01e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—PIK3CA—colon cancer	2.68e-06	9e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—PIK3CA—colon cancer	2.63e-06	8.86e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—PIK3CA—colon cancer	2.63e-06	8.84e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PIK3CA—colon cancer	2.63e-06	8.83e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TP53—colon cancer	2.59e-06	8.71e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PTGS2—colon cancer	2.57e-06	8.65e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TP53—colon cancer	2.55e-06	8.57e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TP53—colon cancer	2.54e-06	8.55e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—EP300—colon cancer	2.52e-06	8.49e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PPARG—colon cancer	2.52e-06	8.48e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—EP300—colon cancer	2.5e-06	8.42e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PIK3CA—colon cancer	2.48e-06	8.34e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—HRAS—colon cancer	2.48e-06	8.33e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—HRAS—colon cancer	2.44e-06	8.19e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—HRAS—colon cancer	2.43e-06	8.18e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—AKT1—colon cancer	2.19e-06	7.35e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—AKT1—colon cancer	2.15e-06	7.24e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—AKT1—colon cancer	2.15e-06	7.22e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—AKT1—colon cancer	2.15e-06	7.21e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—EP300—colon cancer	2.14e-06	7.19e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PIK3CA—colon cancer	2.03e-06	6.83e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—AKT1—colon cancer	2.03e-06	6.82e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PTGS2—colon cancer	1.98e-06	6.67e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PIK3CA—colon cancer	1.98e-06	6.66e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PIK3CA—colon cancer	1.87e-06	6.28e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PIK3CA—colon cancer	1.85e-06	6.23e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—AKT1—colon cancer	1.66e-06	5.58e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—EP300—colon cancer	1.65e-06	5.55e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—AKT1—colon cancer	1.62e-06	5.44e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PIK3CA—colon cancer	1.58e-06	5.32e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—AKT1—colon cancer	1.53e-06	5.13e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—AKT1—colon cancer	1.51e-06	5.09e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—AKT1—colon cancer	1.29e-06	4.35e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PIK3CA—colon cancer	1.22e-06	4.11e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—AKT1—colon cancer	9.97e-07	3.35e-05	CbGpPWpGaD
